Approximately 90% of all lymphomas are classified as non-Hodgkin lymphoma (NHL), a subtype of lymphoma originating in other parts of the immune system outside the lymph nodes. Adult NHL may be classified as either B-cell lymphoma, T-cell lymphoma, or natural killer cell lymphoma, according to the World Health Organization's (WHO) categorization system. According to the statistics, about one and a half million new people are diagnosed with cancer in a year in Bangladesh, among which more than seven thousand people are affected by various blood cancers. Non-Hodgkin and Hodgkin lymphoma, leukaemia, and myeloma belong to blood cancers. Treatment also varies depending on the disease's type and stage or risk. The paper aims to express the current condition of NHL & the treatment approach for this disease by analysing the literature and data of Bangladesh.

Thalassemia is a genetic disorder caused by the inheritance of mutated and abnormal genes involved in the production of hemoglobin from the parents. Thalassemia is most seen in Mediterranean region, Middle East, South-East Asia, Africa, and Indian subcontinent. It is also known as The Mediterranean Disease. The study aims to focus on the awareness of thalassemia among the population of Kolkata, emphasizing on college and university going students. A questionnaire-based survey was conducted among 55 willing participants in a 6-week tenure, from June to July 2022. The study used data visualization method and descriptive statistics for understanding the level of awareness, perception about thalassemia among the participants. The mean knowledge percentage was 25.43% which was analyzed by calculating the points obtained by the participants allotted to each question, the point range was 2­–22 in which only 6 i.e., 10.9% of people had an excellent knowledge of the disease. The points acquired ranged from 8–22 i.e., 4 to 11 questions, more than half of the participants (60%, 33) believe there is a cure for thalassemia and almost 44% (24) participants believe screening of thalassemia can be done only by blood tests. This work focuses on the scarcity of information and degree of misconception about thalassemia. It calls for an urgent, routine need of thalassemia awareness program in the population.

Introduction: Autism spectrum disorder (ASD) is a neurodevelopmental disorder. The ADI-R and ADOS can be used to confirm ASD. These tools have not been tested in a non-sighted population.

Through our clinical case, we highlight the clinical and therapeutic complexity of visually impaired children with ASD.

Case report: A., 4 years and 7 months old, was admitted to the department for a diagnostic evaluation of a communication and language disorder concomitant with congenital blindness. At birth, bilateral anophthalmia was diagnosed. The complete pediatric evaluation was normal.

After profound clinical observation, the diagnosis of ASD in comorbidity with congenital blindness was retained. The management was multidisciplinary.

Discussion: ASD is the most clinically noted and scientifically studied disorder in visually impaired children. Specialists find difficulties in differentiating between the original developmental symptoms of visually impaired children and the symptoms relevant to ASD.

Diagnostic investigation has been based on clinical observation. Several authors have demonstrated that careful observation can differentiate social interaction disorders caused by blindness from those of ASD.

The treatment of children with ASD is essentially based on visual access to information, not adapted to ASD children with blindness.

Conclusion: Blindness associated with ASD is a dual handicap. Validation of diagnostic instruments for ASD, developing appropriate therapeutic interventions for these patients are crucial.